$REPL
Replimune Group, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is REPL up today? It is at $12.23 (+3.38%), and our scanner flagged it 243 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment REPL spikes, and full due diligence on REPL — key stats, earnings, dilution and insider activity. Free.
Get free $REPL alerts the moment volume spikes
Our scanner flagged $REPL 243 times in the last 30 days. Create a free account to track $REPL, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $12.23
- Change today
- +3.38%
- Previous close
- $11.83
- 52-week range
- $1.50 – $13.86
- Market cap
- $993M
- Institutional own.
- 99.9%
- Total held
- 99.9%
- Tradeable float
- 84K 0% of shares · after 100% institutions
- Short interest
- 23.7M ▼ -0% vs prior · as of 2026-07-15
- Days to cover
- 9.4d
- Avg daily volume
- 4.6M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.1x
- 15m
- 0.2x
- 1h
- 0.2x
- 1D
- 0.0x
Get free REPL + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $REPL up today?
REPL is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on REPL today.
Likely catalystReplimune Announces Favorable Outcome of FDA's Cellular,, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders selling0 buys, 7 sells last 3 months (11/14 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Sarchi Christopher Officer | Sold (automatic/other) | -12K 0.01% of company | sold 6.2% | 181K | $111K at $9.24 | Jun 1, 26 |
Hill Emily Luisa Officer | Sold (automatic/other) | -8K | sold 3.2% | 237K | $40K at $5.08 | May 18, 26 |
Patel Sushil Officer | Sold (automatic/other) | -37K 0.04% of company | sold 4.8% | 747K | $190K at $5.08 | May 18, 26 |
Astley-Sparke Philip Director | Sold (automatic/other) | -18K 0.02% of company | sold 1.2% | 1.41M | $90K at $5.08 | May 18, 26 |
Sarchi Christopher Officer | Sold (automatic/other) | -9K 0.01% of company | sold 4.3% | 193K | $44K at $5.08 | May 18, 26 |
Schwendenman Andrew Officer | Sold (automatic/other) | -8K | sold 6.9% | 107K | $40K at $5.08 | May 18, 26 |
Xynos Konstantinos Officer | Sold (automatic/other) | -14K 0.02% of company | sold 5.6% | 236K | $71K at $5.08 | May 18, 26 |
Sarchi Christopher Officer | Sold (automatic/other) | -7K | sold 4.1% | 152K | $52K at $8.01 | Apr 2, 26 |
Sarchi Christopher Officer | Acquired (grant/award) | +50K 0.06% of company | added 33% | 202K | n/a | Apr 1, 26 |
Hill Emily Luisa Officer | Acquired (grant/award) | +50K 0.06% of company | added 26% | 244K | n/a | Apr 1, 26 |
Patel Sushil Officer | Acquired (grant/award) | +251K 0.3% of company | added 47% | 785K | n/a | Apr 1, 26 |
Schwendenman Andrew Officer | Acquired (grant/award) | +37K 0.04% of company | added 47% | 115K | n/a | Apr 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfActive shelf on file — the company can issue new shares on demand (valid ~3 years). If $REPL runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$REPL Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$REPL Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to REPL
Comparable names in biological products, (no diagnostic substances), closest in size first.
REPL stock FAQ
Why is $REPL up today?
REPL is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on REPL today.
What is the REPL stock price today?
REPL last traded at $12.23, up 3.38% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live REPL alerts?
The REPL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged REPL 243 times in the last 30 days.
What exchange is REPL on?
REPL (Replimune Group, Inc.) trades on XNAS, with a market cap of about $993M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is REPL good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge REPL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.